Literature DB >> 402689

Experimental palatal candidosis and saliva flow in monkeys.

I Olsen, H R Haanaes.   

Abstract

Maxillary acrylic plates, inoculated with Candida albicans, were inserted for 3 weeks in 10 monkeys (Cercopithecus aethiops) (Series I), and reinserted in five of the animals 8 weeks after removal (Series II). To suppress saliva flow oxyphencyclimine was injected intramuscularly (0.125 mg/kg) thrice daily for 3 weeks in six monkeys of Series I, while four controls received no drug. In Series II the oxyphencyclimine dose was doubled in three animals, and two controls were sham-treated with sodium chloride. Mean saliva flow was reduced to 58% after 1 week and to 63% after 3 weeks with the low dose of oxyphencyclimine. The values with the high dose were 56% and 64%, respectively. After 1 week thrush had developed beneath the plates of all monkeys. The patches were more extensive and regressed slower with oxyphencyclimine. Enlarged lesions were seen with the double dose. In Series I intraepithelial invasion by hyphae was detected more frequently and longer after inoculation in the oxyphencyclimine group. Such invasion was not found in biopsies from Series II. It is likely that saliva offers some protection against yeasts colonizing the fitting size of a denture.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 402689     DOI: 10.1111/j.1600-0722.1977.tb00544.x

Source DB:  PubMed          Journal:  Scand J Dent Res        ISSN: 0029-845X


  3 in total

Review 1.  Experimental oral candidiasis in animal models.

Authors:  Y H Samaranayake; L P Samaranayake
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Proteolytic activity of Candida albicans: action on human salivary proteins.

Authors:  G R Germaine; L M Tellefson; G L Johnson
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

3.  Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate.

Authors:  M Edgerton; F A Scannapieco; M S Reddy; M J Levine
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.